Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallium-67 scanning for malignant melanoma.

R Kagan1, T Witt, S Bines

  • 1Department of General Surgery, Rush University, Presbyterian-St. Luke's Hospital, Chicago, Illinois 60612.

Cancer
|January 15, 1988
PubMed
Summary

Gallium-67 scintiscanning offers limited value for melanoma staging. This study found it provided little additional information for clinical staging or treatment decisions in melanoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.

Archives of osteoporosis·2023
Same author

Screening two biodegradable polymers in enhanced efficiency fertiliser formulations reveals the need to prioritise performance goals.

Journal of environmental management·2021
Same author

Hormone therapy for postmenopausal osteoporosis management.

Climacteric : the journal of the International Menopause Society·2021
Same author

Uterine bleeding with hormone therapies in menopausal women: a systematic review.

Climacteric : the journal of the International Menopause Society·2020
Same author

A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury.

Cardiovascular engineering and technology·2020
Same author

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2019

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Malignant melanoma frequently metastasizes and shows an affinity for gallium-67.
  • Gallium-67 scintiscanning has been used to detect melanoma metastases, but its effectiveness is debated.

Purpose of the Study:

  • To retrospectively analyze the diagnostic utility of gallium-67 scintiscanning in melanoma patients.
  • To evaluate the effectiveness of gallium-67 scans for screening and staging melanoma.

Main Methods:

  • Retrospective analysis of 296 gallium-67 scans from 222 melanoma patients.
  • Patients were categorized into low suspicion (screening) and high suspicion (metastatic disease) groups.

Main Results:

  • In the low suspicion group, screening gallium scans rarely identified unexpected disease (0.5%).

Related Experiment Videos

  • In the high suspicion group, gallium scans had a 20% false-negative rate, indicating lower sensitivity than standard clinical and radiographic assessments.
  • Gallium-67 scintiscanning provided minimal impact on clinical staging or therapeutic design.

    • Conclusions:

    • Gallium-67 scintiscanning has limited value in the routine investigation of melanoma extent.
    • The technique offers little additional information for clinical staging or treatment planning in melanoma patients.